Korro Bio, Inc. (KRRO) — Stock Valuation & Research

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

KRRO key statistics

Price$15.89
Market cap$234.06M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range5.2-38.421
Beta2.36

Explore KRRO's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.